Tags

Type your tag names separated by a space and hit enter

Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
Asia Pac J Ophthalmol (Phila). 2020 Jul-Aug; 9(4):375-376.AP

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Ruamviboonsuk P
Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.
Lai TYY
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Chang A
Sydney Eye Hospital, Sydney, NSW, Australia.
Lai CC
Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
Mieler WF
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
Lam DSC
International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen, China. C-MER Dennis Lam Eye Centre, C-MER International Eye Care Group Limited, Hong Kong SAR, China.

MeSH

BetacoronavirusCOVID-19ChloroquineCoronavirusCoronavirus InfectionsHumansHydroxychloroquinePandemicsPneumonia, ViralSARS-CoV-2COVID-19 Drug Treatment

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32740072

Citation

Ruamviboonsuk, Paisan, et al. "Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19)." Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.), vol. 9, no. 4, 2020, pp. 375-376.
Ruamviboonsuk P, Lai TYY, Chang A, et al. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19). Asia Pac J Ophthalmol (Phila). 2020;9(4):375-376.
Ruamviboonsuk, P., Lai, T. Y. Y., Chang, A., Lai, C. C., Mieler, W. F., & Lam, D. S. C. (2020). Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19). Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.), 9(4), 375-376. https://doi.org/10.1097/APO.0000000000000316
Ruamviboonsuk P, et al. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19). Asia Pac J Ophthalmol (Phila). 2020 Jul-Aug;9(4):375-376. PubMed PMID: 32740072.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19). AU - Ruamviboonsuk,Paisan, AU - Lai,Timothy Y Y, AU - Chang,Andrew, AU - Lai,Chi-Chun, AU - Mieler,William F, AU - Lam,Dennis S C, PY - 2020/8/3/entrez PY - 2020/8/3/pubmed PY - 2020/8/6/medline SP - 375 EP - 376 JF - Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) JO - Asia Pac J Ophthalmol (Phila) VL - 9 IS - 4 SN - 2162-0989 UR - https://www.unboundmedicine.com/medline/citation/32740072/Re:_Chloroquine__CQ__and_Hydroxychloroquine__HQ__Retinal_Toxicity_Consideration_in_the_Treatment_of_the_Coronavirus_Disease_2019__COVID_19__ DB - PRIME DP - Unbound Medicine ER -